Skip to main content
OpenTrials
Completed

NCT Number: NCT04797845

Patient's TeleMonitoring With Amyotrophic Lateral Sclerosis Treated by Non Invasive Ventilation at Home.

Single-center, prospective pilot study on patients with amyotrophic lateral sclerosis fitted with noninvasive ventilation. The objective is to assess the satisfaction of remote monitoring of patients on non-invasive ventilation after 12 months.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The non invasive ventilation is one of treatments used during the amyotrophic lateral sclerosis when patients have a chronic respiratory failure with alveolar hypoventilation signs. It is demonstrated to improve quality of life and prognosis of the disease. These patients, often severely disabled, generally have a negative experience of repeated hospitalizations. Despite everything, medical and paramedical monitoring is necessary, especially when they are fitted with non invasive ventilation (NIV). A quarterly reassessment is recommended . The possibilities of telemonitoring at home have grown considerably in recent years. In addition, the fans are currently able to remotely transfer a certain amount of data to the service provider, making remote monitoring feasible.Our project therefore aims to assess the feasibility of remote monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) fitted with non invasive ventilation (NIV) through the assessment of their satisfaction, using both medical data and data provided by the ventilator. It is a single-center, prospective pilot study on 30 patients with amyotrophic lateral sclerosis fitted with noninvasive ventilation. Patients will benefit from a quarterly teleconsultation to assess the study criteria through questionnaires during 12 months. Ventilation machines make it possible to carry out remote monitoring, with the help of healthcare providers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

o inclusion criteria:

  • Patient over 18 years,
  • Patient with Amyotrophic Lateral Sclerosis (ALS),
  • Already fitted by Non Invasive Ventilation (NIV),
  • Patient having signed the informed consent
  • Patient affiliated to a social security scheme,
  • Patient with a correct understanding of the French language,
  • Patient with access to an internet connection at home.

For the caregiver:

  • Adult person
  • Be the patient's primary caregiver
  • Have signed the informed consent intended for the caregiver

o exclusion criteria:

  • Patient with another cause of chronic respiratory failure: other neuromuscular diseases, Chronic obstructive pulmonary disease (COPD), diffuse interstitial lung disease,
  • Patient under guardianship or under judicial protection,
  • Patient dependent at least 20 hours out of 24 of the non invasive Ventilation (NIV).

Treatment and study plan

Teleconsultation

Other

Patients will benefit from a quarterly teleconsultation to assess the study criteria through different questionnaires during 12 months.

Primary outcomes

  1. Patient satisfaction of the telemonitoring of non invasive ventilation at home assessed by CSQ-8 at the end of the study

    Time frame: 1 year

    Consumer satisfaction questionnaire (CSQ-8), minimal score is 8 and maximal score is 32. The best score is 32, that mean that patient is satisfied.

Secondary outcomes

  1. Effect of remote monitoring

    Time frame: every 3 months during 1 year

    evaluated by teleconsultation

  2. Patient satisfaction during the study

    Time frame: every 3 months during 1 year

    assessed by Consumer satisfaction questionnaire (CSQ-8), minimal score is 8 and maximal score is 32. The best score is 32, that mean that patient is satisfied.

  3. Feasibility for caregivers assessed by Zarit questionnaire

    Time frame: every 3 months during 1 year

    Painfulness or burden assessment scale. Minimal score is 0 and maximal score is 76. the higher the score, the greater the difficulty.

  4. Feasibility for caregivers assessed by Depression Anxiety Stress Scales (DASS-21) questionnaire

    Time frame: every 3 months during 1 year

    Painfulness or burden assessment scale. Minimal score is 0 and maximal score is 63. the higher the score, the greater the depression.

  5. Feasibility for nursing staff

    Time frame: every 3 months during 1 year

    data collected through remote monitoring

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

"Patient's TeleMonitoring With Amyotrophic Lateral Sclerosis Treated by Non Invasive Ventilation at Home." Tele Monitoring Ventilation At Home (TM-VAH)

Acronym: TS-VAD

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Mar 15, 2021
Registry last updated
Jun 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.